Opinion ID: 4151593
Heading Depth: 2
Heading Rank: 12

Heading: Christina Latta

Text: Plaintiff Christina Latta received her ObTape implant in March 2004. After experiencing discharge and bad odor, Latta underwent four revision surgeries to remove the ObTape, with the final surgery in September 2005. After seeing a television advertisement regarding transvaginal mesh litigation, she filed her complaint in September 2012. Latta argues that she had no reason to suspect ObTape was the cause of her problem because her own doctor did not know. Her doctor said he did not know what was causing Latta’s symptoms but he did not assume it was the ObTape. 3 Rupert noted that “[a] mentor representative documented personal information at my excision procedure . . . . The representative apologized for the injuries that I was experiencing and advised that there were no known defects with this product.” 19 Case: 16-10119 Date Filed: 03/09/2017 Page: 20 of 28 Because of the unusual nature of having so many symptoms, Latta’s doctor suspected that Latta’s body might have an allergy to polypropylene mesh. He told her that procedures with his other ObTape patients were successful, and therefore she assumed her problems were unique to her body. Mentor alleges that Latta was informed that a portion of the ObTape had eroded through her vaginal wall. Before and after each of her four revision surgeries, Latta was told in layman’s terms that her ObTape had eroded. The district court noted that “[a]t the time, Latta believed that her body was rejecting the ObTape. Therefore, Latta knew in July 2004 that there was a likely connection between ObTape and some of her injuries.” In re Mentor Corp. Obtape Transobturator Sling Prods. Liab. Litig., 2016 WL 877773, at  (M.D. Ga. Mar. 2, 2016).